Clinical Trials · NCT05467514
Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- David Sanchez Garcia
- Enrollment
- 35
- Start date
- Jul 2022
- Locations
- 1 site, Mexico
- Primary endpoint
- To assess the effect of liraglutide on carotid intima media thickness in patients with type 1 diabetes mellitus.